Ara
Toplam kayıt 39, listelenen: 1-10
Biphasic Effects Of Ankaferd Blood Stopper On Renal Tubular Apoptosis In The Rat Partial Nephrectomy Model Representing Distinct Levels Of Hemorrhage
(Saudi Med J, 2010)
Objectives: To investigate the effect of Ankaferd Blood Stopper (ABS), on renal tubular apoptosis and on expressions of endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and apoptosis ...
Ultrastructural Analyses Of The Novel Chimeric Hemostatic Agent Generated Via Nanotechnology, Abs Nanohemostat, At The Renal Tissue Level
(2016)
Ankaferd Blood Stopper (ABS), a hemostatic agent of plant origin, has been registered for the prevention of clinical hemorrhages. Currently there is no data regarding the ultrastructural analysis of ABS at the tissue level. ...
Antimicrobial Activity of Ankaferd Blood Stoppera (R) Against Nosocomial Bacterial Pathogens
(Versita, 2010)
The aim of this study is to investigate the in vitro antimicrobial activity of Ankaferd Blood StopperA (R) against methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus species, Escherichia coli, Pseudomonas ...
Branch Retinal Vein Occlusion Associated With Platelet Activation
(2019)
Background/aim: The aim of this study is to study subclinical platelet activation by detecting three important platelet activation parameters of mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit ...
Indications And Outcomes Of Splenectomy For Hematological Disorders
(2019)
Background and Aim Splenectomy is a frequent component of the diagnosis and treatment of hematological disorders. The aim of this study was to define the indications and outcomes of splenectomy for benign and malign ...
Effects Of Ankaferd Hemostat On Helicobacter Pylori Strains And Antibiotic Resistance
(2019)
Background/aim: Ankaferd hemostat (ABS; Ankaferd blood stopper, Istanbul, Turkey) is a folkloric medicinal plant extract. The aim of this study was to determine the effect of Ankaferd hemostat (ABS) on the fate of Helicobacter ...
Discontinuation Of Imatinib Mesylate Could Improve Renal Impairment In Chronic Myeloid Leukemia
(2019)
We aim to report a CML case that had fluid retention and serum creatinine increase under long-term imatinib mesylate (IM) treatment. A 68-year-old woman was diagnosed with chronic myeloid leukemia, and IM was started in ...
Splenic Artery Embolization With Ankaferd Blood Stopper In A Sheep Model
(Aves, 2016)
PURPOSE Splenic artery embolization is a minimally invasive therapeutic procedure utilized in a number of disorders. Ankaferd blood stopper (ABS) is a novel hemostatic agent with a new mechanism of action independent of ...
Generation Of Chimeric “Abs Nanohemostat” Complex And Comparing Its Histomorphological In Vivo Effects To The Traditional Ankaferd Hemostat In Controlled Experimental Partial Nephrectomy Model
(2013)
Purpose. Using the classical Ankaferd Blood Stopper (ABS) solution to create active hemostasis during partial nephrectomy (PN) may not be so effective due to insufficient contact surface between the ABS hemostatic liquid ...